Pan-European supercomputer comes a step closer to reality

European researchers will soon have access to a world-class high performance computing infrastructure, thanks to the new Partnership for Advanced Computing in Europe (PACE) initiative.

PACE brings together the supercomputing centres of 15 European countries, with the goal of strengthening European science, engineering and supercomputer technologies. At a ceremony in Berlin on 17 April, the partners signed a Memorandum of Understanding for the new initiative.

"I am very pleased that, together with our European partners, we have created the conditions for the start of PACE during the German presidency of the EU," said German Research Minister Annette Schavan at the ceremony. "With PACE, scientific computing with supercomputers gains a European dimension."

"Science and the economy need computing power of the highest level," added Achim Bachem of German partner the Gauss Centre for Supercomputing. "Supercomputers have become an essential tool in all of the natural sciences. The great leaps of knowledge of the future will only be made with the help of complex simulations."

PACE was one of the European infrastructure projects highlighted in last October's report from the European Strategy Forum for Research Infrastructures (ESFRI). The central idea behind the new European supercomputer is the joint usage of the capacities of several supercomputers. "It will be a common network with different locations, which will be linked to one another by the most modern networks," explained Dr Schavan.

According to the terms of the Memorandum of Understanding, the partners will spend the next two years putting together concrete proposals on how to best combine their equipment and expertise to implement the project. In the preparation phase, which will run up until 2010, the necessary organisational structures will be created, and clear guidelines will be drawn up concerning the hardware needed at the different locations. When the infrastructure is up and running, a peer review process will ensure that only scientifically excellent projects gain access to the supercomputer.

The start-up costs of the project have been calculated at €400 million, while annual running costs are likely to be around €100 million. Most of these costs will be covered by the Member States involved in the project, with additional funds coming from the EU's Seventh Framework Programme.

The countries involved in the project are Austria, Finland, France, Germany, Greece, Italy, Norway, Poland, Portugal, Spain, Sweden, Switzerland, the Netherlands, Turkey and the UK.

For further information about FP7 funding for research infrastructures, please visit:
http://cordis.europa.eu/fp7/capacities/research-infrastructures_en.html

Related news article:

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...